Qualtec Co

Qualtec Co EBITDA Margin

The EBITDA Margin of Qualtec Co (9165.T) as of Nov 2, 2026 is 11.37 %. In the previous year, EBITDA Margin was 10.04 % — a change of 13.16% (higher).

EBITDA Margin

11.37 %

YoY

13.16%

Last updated:

EBITDA Margin of Qualtec Co is 2026 11.37 % . EBITDA Margin of Qualtec Co was 2025 10.04 % . It decreases by 13.16% higher compared to the previous year.

The Qualtec Co EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2021
4.53 JPY
Jan 1, 2022
11.51 JPY
Jan 1, 2023
9.67 JPY
Jan 1, 2024
10.84 JPY
Jan 1, 2025
10.04 JPY
Jan 1, 2026
11.37 JPY
The Qualtec Co EBITDA Margin history
YEAREBITDA MarginYoY
11.37 %+13.16%
10.04 %-7.33%
10.84 %+12.09%
9.67 %-16.00%
11.51 %+153.87%
4.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Qualtec Co Stock analysis

What does Qualtec Co do? Qualtec Co Ltd generates revenue through three business segments. The Reliability Evaluation Business segment sells testing machines and provides environmental, electrical, and vibration tests, including non-defective and defective product analysis. The Microfabrication Business segment offers laser processing services for build-up boards and flexible printed boards in both prototype and mass production. The Other Business segment delivers genetic mutation detection services for pets, contracted biomedical testing for packaging materials and syringes, and zero innovation consulting services. These services target industrial clients, veterinary clinics, and biomedical companies. The company's Reliability Evaluation segment serves manufacturers requiring product reliability validation. The Microfabrication segment caters to electronics manufacturers needing laser processing for circuit boards. The genetic testing services in the Other Business segment are sold to pet owners and veterinary clinics. Biomedical testing services target companies in the medical device industry. Zero innovation consulting is offered to businesses seeking technology and surface treatment solutions. Qualtec's product portfolio includes testing machines, laser processing services, genetic mutation detection, biomedical testing, and consulting services. The company's primary customers are electronics manufacturers, biomedical firms, veterinary clinics, and pet owners. These segments collectively serve industrial and healthcare markets with specialized technical services. Qualtec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Qualtec Co stock

EBITDA Margin of Qualtec Co is 11.37 % in 2026.

EBITDA Margin of Qualtec Co changed from 10.04 % to 11.37 %, representing a 13.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Qualtec Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Qualtec Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Qualtec Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Qualtec Co